CollPlant Biotechnologies Ltd. (CLGN) Social Stream
COLLPLANT BIOTECHNOLOGIES LTD (CLGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLGN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-20 | 2 | $26 | $20 | $23 | $5.97 | 285.26% |
| 2021-12-27 | 1 | $26 | $20 | $23 | $5.97 | 285.26% |
| 2022-06-13 | 1 | $26 | $17 | $21.5 | $5.97 | 260.13% |
| 2022-12-01 | 1 | $17 | $17 | $17 | $5.97 | 184.76% |
| 2023-04-04 | 2 | $17 | $11 | $14 | $5.97 | 134.51% |
| 2023-08-25 | 2 | $22.75 | $11 | $16.916 | $5.97 | 183.35% |
The Trend in the Analyst Price Target
CLGN's average price target has moved down $0.08 over the prior 42 weeks.
Over the past 148 days, CLGN's average upside potential has been 123.03%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 2 | 17.00 | 11 | 14.000 | 6.74 | 107.72% |
| 2023-04-04 | 2 | 17.00 | 11 | 14.000 | 7.38 | 89.7% |
| 2023-05-25 | 2 | 22.75 | 11 | 16.916 | 7.11 | 137.92% |
| 2023-05-26 | 2 | 22.75 | 11 | 16.916 | 7.25 | 133.32% |
| 2023-08-25 | 2 | 22.75 | 11 | 16.916 | 7.04 | 140.28% |
CLGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 24 months, CLGN's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CLGN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, COLLPLANT BIOTECHNOLOGIES LTD's number of analysts covering the stock is greater than 8.49% of them.
- In terms of how COLLPLANT BIOTECHNOLOGIES LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 527.67% of that group.
- COLLPLANT BIOTECHNOLOGIES LTD's variance in analysts' estimates is lower than -69.51% of Healthcare stocks.
- To contextualize these metrics, consider that out of Medical Equipment stocks, COLLPLANT BIOTECHNOLOGIES LTD's average analyst price target is higher than 152.33% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to COLLPLANT BIOTECHNOLOGIES LTD are NTRB, MYO, and NAOV.
View All Top Stocks by Price Target
Is CLGN a Buy, Hold or Sell? See the POWR Ratings now!